RxDoctor Payments Data

Kenneth Urish

Orthopaedic Surgery · Pittsburgh, PANPI 1063670065

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 89.2% of it on its own, with 7 other manufacturers making up the rest. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$207,491in general payments, 2019–2025

Across 214 payments — averaging $969.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$185K
  • Onkos Surgical, Inc.$19K
  • Musculoskeletal Transplant Foundation Inc.$2K
  • Innovation Technologies Inc$236
  • Stryker$193
  • Zimmer Biomet$144
  • plus $150 from 2 others
$128,713in research payments, 2019–2025

Across 19 payments — averaging $6774.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$73K
  • Onkos Surgical, Inc.$56K

What the payments were for

  • Consulting fees$107,46352%
  • Speaking & faculty fees$73,47935%
  • Travel & lodging$18,8159%
  • Food & beverage$7,7354%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$207,491 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$117,759
Medicare patients
211
Services billed
1,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib111$3,266
Meloxicam130$689
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$407
Naproxen36$263
Mupirocin39$187
Methylprednisolone20$167
Cephalexin63$161
Ibuprofen14$89
Diclofenac Sodium21$71
Oxycodone Hcl15$64
Clindamycin Hcl15$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →